DJIA 17,081.52 1.95 0.01%
NASDAQ 4,573.40 15.70 0.34%
S&P 500 2,000.53 3.79 0.19%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)



company name or ticker

Your September Biotech Back-to-School Calendar

Corrected: European ADRs Higher on Banking Gains

European ADRs Lower on Mining Losses

Biotech Investing: 3 Ways You're Doing It Wrong

Biotech investing might appear easy considering some of the big gains we've witnessed in recent years, but these three common mistakes make it very difficult for the average biotech investor to make money.

Top Swing Trade Ideas for Tuesday, August 19: Apple, Zynga, More

The FDA Gives Itself Room To Move On Amarin's Appeal

Update: Amarin Earnings - Company Making Progress

Amarin's (AMRN) CEO John Thero on Q2 2014 Results - Earnings Call Transcript

Amarin: Starting To Show Some Modest Vascepa Growth

Amarin Moves Higher On Speculation Of Special Protocol Assessment

See More Articles...